[
    [
        {
            "time": "2021-10-07",
            "original_text": "Will Pfizer ETFs Gain on Positive COVID-19 Booster Dose Data?",
            "features": {
                "keywords": [
                    "Pfizer",
                    "ETFs",
                    "Positive",
                    "COVID-19",
                    "Booster",
                    "Dose"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-07",
            "original_text": "Pfizer CEO says company will produce 4 billion COVID-19 doses in 2022",
            "features": {
                "keywords": [
                    "Pfizer",
                    "CEO",
                    "produce",
                    "4 billion",
                    "COVID-19",
                    "doses",
                    "2022"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-07",
            "original_text": "Pfizer CEO: We will 'immediately' distribute vaccine to kids once we have FDA approval",
            "features": {
                "keywords": [
                    "Pfizer",
                    "CEO",
                    "distribute",
                    "vaccine",
                    "kids",
                    "FDA",
                    "approval"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-07",
            "original_text": "Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-Olds",
            "features": {
                "keywords": [
                    "Moderna",
                    "Covid-19",
                    "Vaccine",
                    "Strong",
                    "Immune",
                    "Response",
                    "6-",
                    "11-Year-Olds"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-07",
            "original_text": "Fauci says U.S. is on track to start vaccinating kids aged 5 to 11 by November, as FDA advisers prepare to meet on the matter",
            "features": {
                "keywords": [
                    "Fauci",
                    "U.S.",
                    "vaccinating",
                    "kids",
                    "aged",
                    "5",
                    "11",
                    "November",
                    "FDA",
                    "advisers"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-07",
            "original_text": "Moderna Rises on Report Its Covid Shot Shows Promise in Children 6-11",
            "features": {
                "keywords": [
                    "Moderna",
                    "Rises",
                    "Report",
                    "Covid",
                    "Shot",
                    "Promise",
                    "Children",
                    "6-11"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-07",
            "original_text": "FDA committee to discuss BioNTech/Pfizer's COVID-19 shot in children 5 to 11",
            "features": {
                "keywords": [
                    "FDA",
                    "committee",
                    "discuss",
                    "BioNTech",
                    "Pfizer",
                    "COVID-19",
                    "shot",
                    "children",
                    "5",
                    "11"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]